{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T20:50:59Z","timestamp":1670014259748},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T00:00:00Z","timestamp":1418428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10549-014-3232-z","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T08:51:06Z","timestamp":1418374266000},"page":"245-253","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses\u2019 Health Studies"],"prefix":"10.1007","volume":"149","author":[{"given":"Megan S.","family":"Rice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard A.","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne B.","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles V.","family":"Clevenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,13]]},"reference":[{"issue":"21","key":"3232_CR1","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/jnci\/87.21.1622","volume":"87","author":"C Byrne","year":"1995","unstructured":"Byrne C et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87(21):1622\u20131629","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"3232_CR2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jnci\/87.9.670","volume":"87","author":"NF Boyd","year":"1995","unstructured":"Boyd NF et al (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87(9):670\u2013675","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3232_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10911-008-9063-y","volume":"13","author":"SS Tworoger","year":"2008","unstructured":"Tworoger SS, Hankinson SE (2008) Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia 13(1):41\u201353","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"8","key":"3232_CR4","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/sj.bjc.6600537","volume":"87","author":"NF Boyd","year":"2002","unstructured":"Boyd NF et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87(8):876\u2013882","journal-title":"Br J Cancer"},{"issue":"3","key":"3232_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-006-9454-y","volume":"105","author":"GA Greendale","year":"2007","unstructured":"Greendale GA et al (2007) Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res Treat 105(3):337\u2013346","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"3232_CR6","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1002\/ijc.22971","volume":"121","author":"Y Bremnes","year":"2007","unstructured":"Bremnes Y et al (2007) Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int J Cancer 121(11):2506\u20132511","journal-title":"Int J Cancer"},{"issue":"8","key":"3232_CR7","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/ijc.22834","volume":"121","author":"G Maskarinec","year":"2007","unstructured":"Maskarinec G et al (2007) IGF-I and mammographic density in four geographic locations: a pooled analysis. Int J Cancer 121(8):1786\u20131792","journal-title":"Int J Cancer"},{"issue":"11 Pt 1","key":"3232_CR8","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1158\/1055-9965.EPI-05-0558","volume":"14","author":"RM Tamimi","year":"2005","unstructured":"Tamimi RM et al (2005) Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomark Prev. 14(11 Pt 1):2641\u20132647","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"16","key":"3232_CR9","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1158\/0008-5472.CAN-09-0280","volume":"69","author":"K Walker","year":"2009","unstructured":"Walker K et al (2009) Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res 69(16):6490\u20136499","journal-title":"Cancer Res"},{"issue":"3","key":"3232_CR10","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/bcr2325","volume":"11","author":"VA McCormack","year":"2009","unstructured":"McCormack VA et al (2009) Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women. Breast Cancer Res 11(3):R38","journal-title":"Breast Cancer Res"},{"issue":"5","key":"3232_CR11","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/bcr3041","volume":"13","author":"A Pettersson","year":"2011","unstructured":"Pettersson A et al (2011) Nondense mammographic area and risk of breast cancer. Breast Cancer Res 13(5):R100","journal-title":"Breast Cancer Res"},{"issue":"5","key":"3232_CR12","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/bcr3044","volume":"13","author":"M Lokate","year":"2011","unstructured":"Lokate M et al (2011) Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res 13(5):R103. doi: 10.1186\/bcr3044","journal-title":"Breast Cancer Res"},{"issue":"10","key":"3232_CR13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF03348932","volume":"16","author":"T Hoffmann","year":"1993","unstructured":"Hoffmann T, Penel C, Ronin C (1993) Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance. J Endocrinol Invest 16(10):807\u2013816","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"3232_CR14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/edrv-16-3-354","volume":"16","author":"YN Sinha","year":"1995","unstructured":"Sinha YN (1995) Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 16(3):354\u2013369","journal-title":"Endocr Rev"},{"issue":"7","key":"3232_CR15","first-page":"2433","volume":"40","author":"PW Gout","year":"1980","unstructured":"Gout PW, Beer CT, Noble RL (1980) Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 40(7):2433\u20132436","journal-title":"Cancer Res"},{"key":"3232_CR16","doi-asserted-by":"crossref","unstructured":"Tworoger, S.S., et al., (2014) Bioactive prolactin levels and risk of breast cancer: a nested case\u2013control study. Cancer Epidemiol Biomark Prev","DOI":"10.1158\/1055-9965.EPI-14-0896"},{"issue":"3","key":"3232_CR17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1055-9965.EPI-04-0561","volume":"14","author":"ES Schernhammer","year":"2005","unstructured":"Schernhammer ES et al (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomark Prev 14(3):699\u2013704","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"3232_CR18","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-05-3369","volume":"66","author":"SS Tworoger","year":"2006","unstructured":"Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66(4):2476\u20132482","journal-title":"Cancer Res"},{"issue":"1","key":"3232_CR19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1055-9965.EPI-08-0637","volume":"18","author":"ES Schernhammer","year":"2009","unstructured":"Schernhammer ES, Hankinson SE (2009) Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses\u2019 Health Study cohort. Cancer Epidemiol Biomark Prev 18(1):74\u201379","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9113","key":"3232_CR20","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","volume":"351","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE et al (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351(9113):1393\u20131396","journal-title":"Lancet"},{"issue":"2","key":"3232_CR21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/erc.1.01149","volume":"13","author":"ES Schernhammer","year":"2006","unstructured":"Schernhammer ES et al (2006) Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer 13(2):583\u2013592","journal-title":"Endocr Relat Cancer"},{"key":"3232_CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00401706.1983.10487848","volume":"25","author":"B Rosner","year":"1983","unstructured":"Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165\u2013172","journal-title":"Technometrics"},{"issue":"3","key":"3232_CR23","first-page":"695","volume":"146","author":"CV Clevenger","year":"1995","unstructured":"Clevenger CV et al (1995) Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine\/paracrine loop. Am J Pathol 146(3):695\u2013705","journal-title":"Am J Pathol"},{"issue":"6","key":"3232_CR24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/aje\/kwm348","volume":"167","author":"B Rosner","year":"2008","unstructured":"Rosner B et al (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167(6):653\u2013666","journal-title":"Am J Epidemiol"},{"issue":"11","key":"3232_CR25","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1158\/1055-9965.EPI-05-0558","volume":"14","author":"RM Tamimi","year":"2005","unstructured":"Tamimi RM et al (2005) Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomark Prev 14(11):2641\u20132647","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"3232_CR26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-2007-1013563","volume":"17","author":"JT Emerman","year":"1985","unstructured":"Emerman JT et al (1985) Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 17(8):421\u2013424","journal-title":"Horm Metab Res"},{"issue":"3","key":"3232_CR27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/bjc.1992.92","volume":"65","author":"PR Maddox","year":"1992","unstructured":"Maddox PR, Jones DL, Mansel RE (1992) Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer. Br J Cancer 65(3):456\u2013460","journal-title":"Br J Cancer"},{"issue":"5","key":"3232_CR28","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1055-9965.EPI-05-0848","volume":"15","author":"SA Missmer","year":"2006","unstructured":"Missmer SA et al (2006) Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomark Prev 15(5):972\u2013978","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"3232_CR29","first-page":"649","volume":"4","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE et al (1995) Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomark Prev 4(6):649\u2013654","journal-title":"Cancer Epidemiol Biomark Prev"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-3232-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3232-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T11:18:55Z","timestamp":1566127135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-3232-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3232"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-3232-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,13]]}}}